{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-035948","form_type":"8-K","ticker":"SGMO","cik":"0001001233","company_name":"SANGAMO THERAPEUTICS, INC","filed_at":"2023-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.774914+00:00","generated_at":"2026-06-09T01:41:28.757003+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Sangamo reports Q3 net loss $104.2M, cuts 40% of workforce, focuses on neurology","bullets":["Net loss $104.2M ($0.59/share) vs $53.2M ($0.34) year ago; revenue $9.4M down from $26.5M.","Workforce reduction ~40% (~162 roles); Brisbane HQ to close early 2024; headquarters move to Richmond, CA.","COO Mark McClung and CSO Jason Fontenot leaving Jan 2, 2024; Amy Pooler and Gregory Davis appointed heads of Research and Technology.","Cash $132.1M at Sep 30, 2023; expects runway into Q3 2024; non-GAAP opex 2024 ~$115-135M (down ~50%).","Deferring new investments in Fabry and CAR-Treg programs; seeking partners/investors; Fabry Phase 1/2 data update expected early 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-035948","json":"https://secwatch.observer/filing/0001628280-23-035948.json","markdown":"https://secwatch.observer/filing/0001628280-23-035948.md","text":"https://secwatch.observer/filing/0001628280-23-035948.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001233/000162828023035948/0001628280-23-035948-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001233/000162828023035948/sgmo-20231101.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T01:41:28.757003+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}